Dr. Elizabeth Brem is a UC Irvine Health hematologist-oncologist who specializes in the diagnosis and treatment of lymphoma and other hematologic malignancies.
After earning her medical degree magna cum laude from SUNY Buffalo, Brem completed an internal medicine residency and a hematology/oncology fellowship at Beth Israel Deaconess Medical Center in Boston, where she also was a clinical fellow at Harvard Medical School. Also in Boston, she did research training at the Dana Farber Cancer Institute in the lab of Dr. Anthony Letai, studying the Bcl-2 family of proteins and its role as a therapeutic target and source of therapy resistance in lymphomas.
Brem is an active member of the American Society of Hematology, the Southwest Oncology Group and the University of California Hematologic Malignancies Consortium. Her goal is to help design and conduct innovative clinical trials for patients with lymphoma.